Clinical trials are testing for these effects, with early results indicating better blood sugar control and the potential to reduce the need for other diabetes drugs
We then used 100 nM S961 administered through the Alzet osmotic pump 2004 (Fig
In general, and similar to FDA-approved labeling for GLP-1 weight-management medications, you may be considered for a GLP-1 prescription if you: Have a BMI of 30 or higher (obesity), or Have a BMI between 2729.9 (overweight) plus a weight-related health condition Weight-related conditions can include high blood pressure, type 2 diabetes, sleep apnea, high cholesterol, or PCOS (Polycystic Ovary Syndrome), for example
Patients with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2) should not use this medication
Current UK guidance from the MHRA and manufacturer clearly states that Wegovy (semaglutide 2.4 mg) should not be used during lactation due to insufficient data on its transfer into breast milk and potential effects on nursing infants
Its a partnership between the medication and your diet to achieve your weight loss goals